JNK1 determines the oncogenic or tumor-suppressive activity of the integrin-linked kinase in human rhabdomyosarcoma
Adam D. Durbin(St. Jude Children's Research Hospital), David Malkin(University of Toronto)
Cited by 43
Related Papers
Immune Checkpoint Inhibition for Hypermutant Glioblastoma Multiforme Resulting From Germline Biallelic Mismatch Repair Deficiency
|Journal of Clinical Oncology|2016|867
Rapid, reliable, and reproducible molecular sub-grouping of clinical medulloblastoma samples
|Acta Neuropathologica|2011|387
Cancer Survivorship—Genetic Susceptibility and Second Primary Cancers: Research Strategies and Recommendations
|JNCI Journal of the National Cancer Institute|2006|344